{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-023096","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.575381+00:00","generated_at":"2026-06-01T05:41:00.072498+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Heng Fai Ambrose Chan resigns; Jason T. Grady appointed to board","bullets":["Heng Fai Ambrose Chan resigned as director effective June 6, 2024, with no disagreement.","Board appointed Jason T. Grady as director effective June 6, 2024.","Grady is COO of DSS, Inc., President of Premier Packaging, President/COO of DSS Wealth Management and BioLife Science.","No arrangement or understanding regarding Grady's appointment; no family relationship or related party transaction."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-023096","json":"https://secwatch.observer/filing/0001493152-24-023096.json","markdown":"https://secwatch.observer/filing/0001493152-24-023096.md","text":"https://secwatch.observer/filing/0001493152-24-023096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/0001493152-24-023096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:41:00.072498+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8897fa56b7","claim":"Jason T. Grady was appointed as Director at IMPACT BIOMEDICAL INC..","evidence_excerpt":"Additionally on June 6, 2024, the Board of Directors of the Company appointed Jason T. Grady to serve as a Director of the Company, effective as of the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/0001493152-24-023096-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"af45e7035e","claim":"Heng Fai Ambrose Chan resigned as Director at IMPACT BIOMEDICAL INC..","evidence_excerpt":"On June 6, 2024, Heng Fai Ambrose Chan notified Impact Biomedical, Inc. (the “Company”) that he is resigning as a member of the Board of Directors of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/0001493152-24-023096-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}